SillaJen Faces Delisting Despite New Owner's Capital Injection
Shareholders Protest Exchange’s Decision
Executive Summary
Oncolytic virus firm SillaJen, which hoped to get back on track and resume stock trading after it found a new owner last year, is set to be delisted from Korea’s Kosdaq market as the exchange makes a preliminary decision.